Anzeige
Mehr »
Login
Dienstag, 05.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
300% Aktienanstieg war nur der Vorgeschmack – Warum diese Kupferstory noch besser wird!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JAES | ISIN: CA38045Y1025 | Ticker-Symbol: GGD
Tradegate
05.11.24
15:19 Uhr
0,961 Euro
-0,028
-2,83 %
Branche
Rohstoffe
Aktienmarkt
Sonstige
1-Jahres-Chart
GOGOLD RESOURCES INC Chart 1 Jahr
5-Tage-Chart
GOGOLD RESOURCES INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,9651,00020:42
0,9690,99520:09
PR Newswire
198 Leser
Artikel bewerten:
(1)

GoGold Resources Inc.: GoGold Releases Q3 2024 Financial Results

Shares Outstanding: 329,452,261
Trading Symbols: TSX: GGD
OTCQX: GLGDF

HALIFAX, NS, Aug. 8, 2024 /PRNewswire/ - GoGold Resources Inc. (TSX: GGD) (OTCQX: GLGDF) ("GoGold", "the Company") is pleased to announce the financial results for the quarter ending June 30, 2024. The Company generated revenue of $10.4 million (all amounts are in U.S. dollars) from the sale of 365,119 silver equivalent ounces.

"During the quarter, we passed 10 years of continuous production at Parral. We constantly make efforts to optimize our operations and congratulate the team on completing 10 years of production," said Brad Langille, President and CEO. "We feel that the next decade plus of growth in GoGold lies within our flagship Los Ricos district, with the immediate catalyst being the release of the results of our definitive feasibility study in September at Los Ricos South. During the engineering work for the feasibility study we have redesigned the mine plan to have a bulk underground operation for at least the first decade of production. We are confident that we will be issued an underground permit and therefore are preparing to execute on long lead time items such as construction of a power line and paying deposits for certain major components."

Highlights for the quarter ending June 30, 2024:

  • Cash of $76.4 million USD
  • Revenue of $10.4 million on the sale of 365,119 silver equivalent ounces at a realized price per ounce of $28.37 per oz
  • Production of 400,236 silver equivalent ounces, consisting of 138,708 silver ounces, 2,436 gold ounces, 148 copper tonnes, and 125 zinc tonnes
  • First sale of zinc precipitate from SART zinc expansion
  • Adjusted cash cost per silver equivalent ounce of $18.54
  • Adjusted all in sustaining cost per silver equivalent ounce of $24.59

Following are tables showing summarized financial information and key performance indicators:

Summarized Consolidated Financial Information

Three months ended Jun 30


Nine months ended Jun 30

(in thousands USD, except per share amounts)

2024

2023


2024

2023

Revenue

$ 10,358

$ 8,485


$ 26,097

$ 24,570

Cost of sales, including depreciation1

4,590

6,272


17,173

28,796

Operating income (loss)1

3,600

245


1,869

(10,149)

Net (loss) income1

(483)

2,604


864

(3,593)

Basic net (loss) income per share1

(0.002)

0.008


0.003

(0.012)

Cash flow used in operations

(2,157)

(299)


(9,819)

(7,210)

1Affected by inventory net realizable value adjustments of: Q3-24 $2,957, Q3-23 nil, YTD-24 $3,276, YTD-23 ($10,500)

Key Performance Indicators 1

Three months ended Jun 30


Nine months ended Jun 30

(in thousands USD, except per ounce amounts)

2024

2023


2024

2023

Total tonnes stacked

425,804

407,738


1,223,665

1,077,305

Silver equivalent ounces sold

365,119

360,011


1,044,346

1,127,508

Adjusted AISC per silver equivalent ounce2

$ 24.59

$ 20.85


$ 24.47

$ 19.38

Adjusted Cash cost per silver equivalent ounce2

$ 18.54

$ 15.24


$ 17.59

$ 13.99

Realized silver price

$ 28.37

$ 23.57


$ 24.99

$ 21.79

1Key performance indicators are unaudited non-GAAP measures, see reconciliation in MD&A.

2Gold and copper are converted using average market prices.

This news release should be read in conjunction with the interim condensed consolidated financial statements for the quarter ended June 30, 2024, notes to the financial statements, and management's discussion and analysis for the quarter ended June 30, 2024, which have been filed on SEDAR and are available on the Company's website.

Technical information contained in this news release with respect to GoGold has been reviewed and approved by Mr. Bob Harris, P.Eng., who is a qualified person for the purposes of NI 43-101.

About GoGold Resources

GoGold Resources (TSX: GGD) is a Canadian-based silver and gold producer focused on operating, developing, exploring and acquiring high quality projects in Mexico. The Company operates the Parral Tailings mine in the state of Chihuahua and has the Los Ricos South and Los Ricos North exploration projects in the state of Jalisco. Headquartered in Halifax, NS, GoGold is building a portfolio of low cost, high margin projects. For more information visit gogoldresources.com.

CAUTIONARY STATEMENT:

The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws, and may not be offered or sold within the United States or to, or for the benefit of, U.S. persons (as defined in Regulation S under the U.S. Securities Act) except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities laws or pursuant to exemptions therefrom. This release does not constitute an offer to sell or a solicitation of an offer to buy of any of GoGold's securities in the United States.

This news release may contain "forward-looking information" as defined in applicable Canadian securities legislation. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the Parral tailings project, the Los Ricos project, future operating margins, future production and processing, and future plans and objectives of GoGold, constitute forward looking information that involve various risks and uncertainties. Forward-looking information is based on a number of factors and assumptions which have been used to develop such information but which may prove to be incorrect, including, but not limited to, assumptions in connection with the continuance of GoGold and its subsidiaries as a going concern, general economic and market conditions, mineral prices, the accuracy of mineral resource estimates, and the performance of the Parral project There can be no assurance that such information will prove to be accurate and actual results and future events could differ materially from those anticipated in such forward-looking information.

Important factors that could cause actual results to differ materially from GoGold's expectations include exploration and development risks associated with the GoGold's projects, the failure to establish estimated mineral resources or mineral reserves, volatility of commodity prices, variations of recovery rates, and global economic conditions. For additional information with respect to risk factors applicable to GoGold, reference should be made to GoGold's continuous disclosure materials filed from time to time with securities regulators, including, but not limited to, GoGold's Annual Information Form. The forward-looking information contained in this release is made as of the date of this release.

Cautionary non-GAAP Measures and Additional GAAP Measures

Note that for purposes of this section, GAAP refers to IFRS. The Company believes that investors use certain non-GAAP and additional GAAP measures as indicators to assess mining companies. They are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared with GAAP. Non-GAAP and additional GAAP measures do not have a standardized meaning prescribed under IFRS and therefore may not be comparable to similar measures presented by other companies.

Additional GAAP measures that are presented on the face of the Company's consolidated statements of comprehensive income include "Operating income (loss)". These measures are intended to provide an indication of the Company's mine and operating performance. Per ounce measures are calculated by dividing the relevant mining and processing costs and total costs by the tonnes of ore processed in the period. "Adjusted cash costs per ounce" and "Adjusted all-in sustaining costs per ounce" are used in this analysis and are non-GAAP terms typically used by mining companies to assess the level of gross margin available to the Company by subtracting these costs from the unit price realized during the period. These non-GAAP terms are also used to assess the ability of a mining company to generate cash flow from operations. There may be some variation in the method of computation of these metrics as determined by the Company compared with other mining companies. In this context, "Adjusted cash costs per ounce" reflects the cash operating costs allocated from in-process and dore inventory associated with ounces of silver and gold sold in the period. "Adjusted cash costs per ounce" may vary from one period to another due to operating efficiencies, grade of material processed and silver/gold recovery rates in the period. "Adjusted all-in sustaining costs per ounce" include total cash costs, exploration, corporate and administrative, share based compensation and sustaining capital costs. For a reconciliation of non-GAAP and GAAP measures, please refer to the Management Discussion and Analysis dated August 7, 2024 for the three months ended June 30, 2024, as presented on SEDAR.

SOURCE GoGold Resources Inc.

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.